Aktis Oncology Inc <AKTS.O>: Oppenheimer Initiates Coverage With Outperform Rating; Price Target $40
AKTS•Related News
T3 Defense CEO Menny Shalom presents at H.C. Wainwright Global Investment Conference
DFNS•
Cornerstone Building Brands names Matthew E. Garth CFO effective Sept. 14, 2026
CNR•
Lufax agrees to pay USD 29.38 million to extend maturity of Ping An-held debt by one year
LU•
Copper Property CTL Pass Through Trust extends termination date to Oct. 27 via certificateholder written consent
CPPTL•
Geron publishes community oncology chart review presentation on imetelstat in MDS
GERN•